|Articles|July 1, 2002
Melanoma discovery quickens research pace
Gene mutation a breakthrough, but much more testing neededThe identification of the BRAF gene mutation's presence in 66 percentof malignant melanomas received much fanfare last month, but physiciansstill are years shy of reaping the rewards of the discovery through diagnostictools and drug therapies.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 2
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5













